Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathwaysXinyan Wu, Akhilesh Pandey, Santosh Renuse et al.|Oncotarget|2015Cited by 67
The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancerXinyan Wu, Akhilesh Pandey, Muhammad Saddiq Zahari et al.|Oncotarget|2016Cited by 60
Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arraysMustafa A. Barbhuiya, Harsha Gowda|Oncotarget|2018Cited by 5